Tuesday, March 16, 2021 5:21:06 PM
Red Light Holland Corp. has completed the sale and import of the company's high-grade consumer packaged goods (iMicrodose packs) from the Netherlands to Canada under a Health Canada psilocybin import permit obtained by CCrest Laboratories Inc. in partnership with Shaman Pharma Corp.
The transaction between Red Light Holland and the Montreal, Que., based cGMP lab, CCrest Laboratories, is the first of a multiphase project to expand into the mental wellness pharmaceutical sector by demonstrating a legally compliant route for supplying raw materials containing psychoactive molecules, produced abroad by Red Light Holland and imported into Canada.
"Today is another ground-breaking, precedent-setting and defining leap forward for the entire psychedelic sector as Red Light Holland has successfully expanded the reach of iMicrodose packs across international borders. As interest in novel psychedelic therapies increase on a daily basis, we will continue to aim to take our natural-occurring packaged psilocybin products to global markets, allowing Red Light Holland to increase our distribution and sales channels. The agreement with Shaman Pharma to utilize its partnership with CCrest Laboratories is part of Red Light Holland's growth strategy, complementing the international groundwork which we established in the Netherlands, as one of the only legal sources for producing natural raw materials containing psilocybin," said Todd Shapiro, chief executive officer and director of Red Light Holland. "The collaboration with Shaman Pharma, who have successfully received our iMicrodose packs on Canadian soil, simply put, is a significant day for the company and its shareholders. We are very proud to have our Netherlands-grown magic truffles designed for responsible use via education and information in Canada. They've arrived home and Red Light Holland continues to trailblaze across the world."
The transaction is performed with the intent of exploring continued collaboration beyond successfully completing the shipment of Red Light Holland's consumer packaged goods under a Health Canada import permit. The multiphase scientific undertaking by CCrest Laboratories is planned to perform each phase of developing viable ingredients to address the demanding requirements of clinical trials, patient's special access programs and the downstream supply of production-ready substances.
"We are delighted to build a relationship with Red Light Holland as we access the global industry for the very best of both product supply and, with recognition of their position as a market leader in establishing a supply chain from Europe to North America, the ability to meet the exacting needs of a globalized medical marketplace," stated Alex Grenier, chief executive officer of Shaman Pharma and president of CCrest Laboratories. "Today, we succeeded in demonstrating our strong ability to navigate the stringent regulatory landscape for conducting international transactions of controlled substances and setting the bar for scientific excellence. Furthermore, through this collaboration with Red Light Holland, we were pleased to find that Mr. Shapiro's vision and ethic is well aligned with compatible long-term objectives for pioneering the psychedelic therapy sector in a manner that exceeds the most complex compliance requirements."
Having successfully completed the transaction, Red Light Holland and Shaman Pharma are jointly looking forward to pursuing the next phases in evaluating the potential of the company's psilocybin-containing raw materials as a viable source for high-quality active pharmaceutical ingredients. This world-first achievement marks an important milestone in securing a stronghold position at the forefront of the industry to supply the eventual manufacturing of psychiatric drugs as well as for other scientific and medical purposes.
As well, subject to regulatory approval, Red Light Holland has engaged HE Capital Markets Ltd. to design and implement a North American multimedia digital advertising campaign for Red Light Holland on certain investor-focused and financial market websites. HE will also provide other media communications services to raise the company's overall corporate profile in North America.
The cash consideration to be paid by the company for these services consists of $30,000 (U.S.) for a three-month campaign. HE acts at arm's length to Red Light Holland and is a London-based investor relations and capital markets advisory firm, providing comprehensive communications solutions to public company clients in North America and Europe through a combination of investor relations, public relations, and digital and social media services. HE's office address is 6 Hays Lane, London Bridge, London, SE1 2HB, United Kingdom.
About Red Light Holland Corp.
The company is an Ontario-based corporation engaged in the production, growth and sale (through existing smart shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.
Recent TRIP News
- Tripadvisor to Host First Quarter 2024 Conference Call on May 8, 2024 • PR Newswire (US) • 04/23/2024 08:05:00 PM
- CHECK-IN TO THE BEST OF THE BEST PLACES TO STAY AROUND THE WORLD • PR Newswire (US) • 04/23/2024 04:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:31:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:29:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:28:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:27:15 PM
- Sunny Days Ahead: Tripadvisor Awards World's Best Beaches • PR Newswire (US) • 02/21/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:36:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:34:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:31:28 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/16/2024 10:20:43 PM
- Cisco Systems Stock Drops 5% Following Restructuring Plan, Berkshire Trims Apple Stake, and Latest News • IH Market News • 02/15/2024 11:34:25 AM
- Tripadvisor, Inc. Earnings Press Release Available on Company's Investor Relations Site • PR Newswire (US) • 02/14/2024 09:06:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:02:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:13:05 PM
- TRIPADVISOR ANNOUNCES FORMATION OF A SPECIAL COMMITTEE OF INDEPENDENT MEMBERS OF ITS BOARD OF DIRECTORS • PR Newswire (US) • 02/12/2024 09:06:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:01:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 02:05:31 PM
- Tripadvisor to Host Fourth Quarter and Full Year 2023 Conference Call on February 15, 2024 • PR Newswire (US) • 01/30/2024 09:05:00 PM
- The Results Are In: Tripadvisor's Top 2024 Destinations According to Global Travelers • PR Newswire (US) • 01/09/2024 12:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 02:03:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 02:02:19 PM
- Tripadvisor Group names Kristen Dalton as President of the Tripadvisor Core Business • PR Newswire (US) • 12/12/2023 12:00:00 PM
- The Best Cruise Lines of the 2023, According to Cruise Critic • PR Newswire (US) • 12/06/2023 10:00:00 AM
- The Best Cruise Lines of 2023 for UK Travellers, According to Cruise Critic • PR Newswire (US) • 12/06/2023 10:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM